News from thoratec corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Oct 07, 2015, 04:15 ET Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Oct 06, 2015, 08:35 ET Thoratec Hebt Die Klinischen Ereignisse Der Jahrestagung Der European Association For Cardio-Thoracic Surgery Hervor
Thoratec Corporation (NASDAQ: THOR), ein weltweit führendes Unternehmen für mechanische Kreislaufsunterstützungstherapien zur Bewahrung,...
Oct 06, 2015, 08:35 ET Présentation par Thoratec des événements cliniques lors de la conférence de l'Association européenne de chirurgie cardio-thoracique
Thoratec Corporation (NASDAQ : THOR), un leader mondial dans les traitements d'assistance circulatoire mécanique pour sauver, assister et rétablir...
Oct 06, 2015, 08:21 ET Thoratec Highlights Clinical Events From The European Association For Cardio-Thoracic Surgery Conference
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Sep 27, 2015, 04:00 ET HeartMate 3™ CE Mark Trial Meets Primary Endpoint
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, today...
Sep 27, 2015, 04:00 ET HeartMate 3™ CE-zulassungsstudie erreicht primären endpunkt
Thoratec Corporation (NASDAQ: THOR), ein weltweit führendes Unternehmen für mechanische Kreislaufsunterstützungs-therapien zur Bewahrung,...
Sep 27, 2015, 04:00 ET L'évaluation du marquage CE du HeartMate 3™ passe le critère principal d'évaluation
Thoratec Corporation (NASDAQ : THOR), chef de file mondial dans le domaine des thérapies d'assistance circulatoire mécanique pour sauver, assister et ...
Sep 14, 2015, 08:45 ET Thoratec Issues Voluntary Device Correction
Thoratec Corporation (NASDAQ: THOR) today issued a voluntary Urgent Medical Device Correction Letter to all hospitals who have patients supported...
Sep 04, 2015, 08:30 ET Thoratec Announces Start Of Shield II™ U.S. Clinical Trial
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Aug 21, 2015, 08:45 ET Thoratec Announces End Of "Go Shop" Period
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Jul 22, 2015, 07:05 ET Thoratec Announces Preliminary Second Quarter Revenue
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Jul 13, 2015, 08:45 ET Thoratec Receives CE Mark Approval For HeartMate PHP™
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Jul 06, 2015, 04:25 ET Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
May 26, 2015, 09:00 ET Thoratec Receives Conditional FDA Approval For The Shield II U.S. Clinical Trial For HeartMate PHP
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
May 26, 2015, 04:25 ET Thoratec Presentation At Goldman Sachs Healthcare Conference To Be Webcast
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, said...
May 07, 2015, 04:02 ET Thoratec® Reports First Quarter 2015 Results
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support (MCS) therapies to save, support and restore failing hearts,...
May 01, 2015, 09:00 ET Thoratec Announces Addition To Senior Management Team
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts,...
Apr 30, 2015, 04:20 ET Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast
Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, said...
Apr 20, 2015, 09:10 ET Thoratec Schedules First Quarter Conference Call, Webcast
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Apr 17, 2015, 03:30 ET ROADMAP Study Demonstrates HeartMate II® Benefits In Ambulatory Advanced Heart Failure Patients
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Apr 16, 2015, 09:49 ET Thoratec Comments On HeartMate II® Data In ENDURANCE Destination Therapy Trial
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Apr 06, 2015, 08:45 ET Thoratec To Webcast Investor Meeting At ISHLT Conference
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Apr 02, 2015, 09:00 ET Thoratec Receives Approval From FDA For Full Expansion Of HeartMate III™ U.S. IDE Clinical Trial
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Feb 25, 2015, 08:45 ET Thoratec Announces Presentations At Investor Conferences For March 2015
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
Feb 10, 2015, 04:02 ET Thoratec® Reports Fourth Quarter 2014 Results
Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...
